1. Reutershan J，Change D，Hayes JK，et al.Protective effects of isoflurane pretreatment in endotoxin-induced lung injury.Anesthesiology，2006，104：511-517.

2. Urner M，Limbach LK，Herrmann IK.Fluorinated groups mediate the immunomodulatory effects of volatile anesthetics in acute cell injury.Am J Respir Cell Mol Biol，2001，45：617-624.

3. Faller S，Strosing KM，Ryter SW，et al.The volatile anesthetic isoflurane prevents ventilator-induced lung injury via phophoinositide 3-kinase/Akt signaling in mice. Anesth Analg，2012，114：747-756.

4. Chung IS，Kim JA，Kim JA et al.Reactive oxygen species by isoflurane mediates inhibition of nuclear Immune response to anesthesia.Anesth Analg 2013，116，327-335.

5. Allaouchiche B，Debon R，Goudable J，et al.Oxidative stress status during exposure to propofol，sevoflurane，and desflurane.Anesth Analg，2001，93：981-985.

6. Bedirli N，Demirtas CY，Akkaya T，et al.Volatile anesthetic preconditioning attenuated sepsis induced lung inflammation. J Surg Res，2012，178：e17-e23.

7. C.Hofstetter，K.A.Boost，M.F Londor，et al.Anti-inflammatory effects of sevoflurane and mild hypothermia in endotoxemic rats.Acta Anaesthesiol Scand，2007，51：893-899.

8. Spyridon Fortis，Peter M.Spieth，Wei-Yang Lu，et al.Effects of anesthetic regimes on inflammatory responses in a rat model of acute lung injury.Intensive Care Med，2012，38：1548-1555.

9. Yusuke Sugasawa，Keisuke Yamaguchi，Seiichiro KumakuraEffects，et al.Effects of sevoflurane and propofol on pulmonary inflammatory responses during lung resection.J Anesth， 2012，26：62-69.

10. H.Thomas Lee，Charles W. Emala，Jin Deok Joo，et al. Isoflurane improves survival and protects against renel and hepatic injury in murine septic peritonitis.Shock，2007，4，：373-379.

11. Hui Wang，Lei Wang，Nan-lin Li，et al.Subanesthetic isoflurane reduces zymosan-induced inflammation in murine kupffer cells by inhibiting ROS-activated p38 MAPK/NF-κB signaling. Oxidative Medicine and Cellular Longevity. 2014，（2014）：851692.

12. Raquel Rodríguez-González，Aurora Baluja，Sonia Veiras Del Río，et al.Effects of sevoflurane postconditioning on cell death，inflammation and TLR expression in human endothelial cells exposed to LPS.Journal of Translational Medicine，2013：11-87.

13. Fr ohlich D，Rothe G，Schwall B，et al.Effects of volatile anaesthetics on human neutrophil oxidative response to the bacterial peptide fMLP.Br J Anaesth，1997，78：718-723.

14. Saad MM，Eom W，Hu G，et al.Persistency and pathway of isoflurane-induced inhibition of superoxide production by neutrophils.Can J Anaesth，2010，57：50-57.

15. Minguet G，de la Riebere G，Franck T，et al.Sevoflurane inhibits equine myeloperoxidase release and activity in vitro. Vet Anaesth Analg，2012，40：166-175.

16. Hiroki Wada，Shuhji Seki，Tetsuya Takahashi，et al.Combined Spinal and General Anesthesia Attenuates Liver Metastasis by Preserving Th1/Th1 Cytokine Balance.Anesthesiology，2007，106：499-506.

17. Kim M，Park SW，Kim M，et al.Isoflurane post-conditioning protects against intestinal ischemia-reperfusion injury and multiorgan dysfunction via transforming growth factor-b1 generation.Ann Surg，2012，255：492-503.

18. Chappell D，Heindl B，Jacob M，et al.Sevoflurane reduces leukocyte and platelet adhesion after ischemia-reperfusion by protecting the endothelial glycocalyx. Anesthesiology，2010，115：483-491.

19. Lango R，Mrozinski P. Clinical importance of anesthetic post-conditioning.Anestezjol Intens Ter，2010，42：206-212.

20. Eckhard Schmid，Stefanie Krajewski，Daniel Bachmann，et al.The volatile anesthetic sevoflurane inhibits activation of neutrophil granulocytes during simulated extracorporeal circulation.International Immunopharmacology，2012，14：202-208.

21. Markovic SN，Knight PR，Murasko DM，et al.Inhibition of interferon stimulation of natural killer cell activity in mice anesthetized with halothane or isoflurane. Anesthesiology，1993，78：700-706.

22. Kawaraguchi Y，Horikawa YT，Murphy AN，et al. Volatile anesthetics protect cancer cells against tumor necrosis actor-related apoptosis-inducing ligand-induced apoptosis via caveolins.Anesthesiology，2011，115：499-508.

23. Habibollahi P，Mahboobi N，smaeili S，et al.Halothane-induced hepatitis：a forgotten issue in developing countries. Hepat Mon，2011，11：3-6.

24. Benson GJ，Brock KA. Halothane-associated hepatitis and methoxyflurane-related nephropathy：a review. J Vet Pharmacol Ther，1998，3：187-196.